Mark Frasier

Mark Frasier is a prominent figure in Parkinson's disease research, currently serving as the Co-Chief Scientific Officer at The Michael J. Fox Foundation for Parkinson's Research.12 He has been with the foundation since 2006, starting as Vice President of Research Programs before assuming his current role in January 2021.1

Career Highlights

Dr. Frasier's career has been dedicated to advancing Parkinson's research and drug development. At the Michael J. Fox Foundation, he leads a team of research professionals who work closely with the Parkinson's research community to develop an innovative agenda for accelerating research and drug development.2 His responsibilities include:

• Identifying promising research proposals
• Managing ongoing projects
• Supporting the foundation's priority in developing biomarkers for Parkinson's disease

Educational Background

Mark Frasier's academic journey includes:

• BS in Biochemistry from the University of Dayton (1994-1998)
• PhD in Pharmacology from Loyola University Chicago (1999-2005)
• Postdoctoral fellowship at Eli Lilly and Company (2004-2006)1

Professional Experience

Before joining the Michael J. Fox Foundation, Dr. Frasier gained valuable experience in various roles:

• Postdoctoral Fellow at Eli Lilly and Company (2004-2006)
• Quality Assurance Chemist at Nestle (September 1998 - July 1999)1

Personal Commitment

Beyond his professional duties, Mark Frasier has demonstrated personal commitment to the cause by participating in Team Fox events, including running the New York ING Marathon and playing golf to raise funds for Parkinson's research.2